HOXA1 and breast carcinoma: These results indicate that in tamoxifen-resistant breast cancer cells, HOTAIRM1 complexes with EZH2, preventing the enzyme from binding to the putative promoter of HOXA1 to deposit repressive H3K27me3 marks.